HCM
BNTX icon

Howard Capital Management’s BioNTech BNTX Stock Holding History

Howard Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,115
Closed -$201K – 344
2025
Q4 		$201K Buy
2,115
+60
+3% +$6.04K ﹤0.01% 425
2025
Q3 		$203K Sell
2,055
-24
-1% -$2.57K ﹤0.01% 422
2025
Q2 		$221K Buy
+2,079
New +$210K ﹤0.01% 390
2025
Q1 		– Sell
-1,925
Closed -$219K – 385
2024
Q4 		$219K Buy
1,925
+63
+3% +$7.19K ﹤0.01% 390
2024
Q3 		$221K Buy
+1,862
New +$171K ﹤0.01% 371

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Howard Capital Management's BNTX Position: Q1 2026 in Review

Howard Capital Management sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 2,115 shares — an estimated $201K sold.

Howard Capital Management first reported a position in BNTX in Q3 2024 and held it in 5 quarters. The position peaked at $221K in Q2 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Howard Capital Management reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Howard Capital Management sold 2,115 BioNTech shares in Q1 2026, an estimated $201K.
  • Howard Capital Management first reported a position in BioNTech in Q3 2024 and held it in 5 quarters.
  • Howard Capital Management's BioNTech position peaked at $221K in Q2 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Howard Capital Management's 13F filing for Q1 2026, filed 5 May 2026.